Stock AXNX AXONICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Axonics, Inc.

Equities

AXNX

US05465P1012

Real-time Estimate Cboe BZX
Other stock markets
 14:31:09 2024-04-29 EDT 		5-day change 1st Jan Change
66.8 USD +0.16% Intraday chart for Axonics, Inc. +0.07% +7.49%
04-04 Boston Scientific, Axonics Receive FTC Second Request on Merger Deal MT
04-04 Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information DJ

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Boston Scientific Announces Results for First Quarter 2024
PR
Boston Scientific, Axonics Receive FTC Second Request on Merger Deal
MT
Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information
DJ
FTC seeks additional information for Boston Scientific's $3.7 bln Axonics deal
RE
Axonics Stockholders Approve Merger Agreement with Boston Scientific
AQ
Axonics Wins Shareholder Approval of Merger With Boston Scientific
MT
Axonics Stockholders Approve Merger Agreement with Boston Scientific
BU
Axonics to File for Review After Patent Board Invalidates Claims in Medtronic Case
MT
Axonics Provides Update on Inter Partes Review Proceedings
BU
Medtronic to Ask Court to Resume Patent Infringement Case Against Axonics After Favorable Patent Office Ruling
MT
Axonics to Sell Rechargeable Sacral Neuromodulation System in Europe Starting April
MT
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
BU
North American Morning Briefing : Stock Futures -2-
DJ
Axonics Responds to ITC Action by Medtronic
BU
Axonics Q4 Earnings, Revenue Rise -- Shares Edge Higher After Hours
MT
Axonics: Q4 Earnings Snapshot
AQ
Axonics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Earnings Flash (AXNX) AXONICS Posts Q4 Revenue $109.7M
MT
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
BU
AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AXNX Stock
  4. News Axonics, Inc.